

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as well as a range of instruments and accessories for tis⦠read more
Healthcare
Medical Instruments & Supplies
25 years
USD
Exclusive to Premium users
$6.10
Price+0.17%
$0.01
$27.512m
Small
-
Premium
Premium
+5.6%
EBITDA Margin-6.0%
Net Profit Margin+3.0%
Free Cash Flow Margin+5.6%
EBITDA Margin-6.0%
Net Profit Margin+3.0%
Free Cash Flow Margin$85.531m
-7.2%
1y CAGR-8.1%
3y CAGR-7.2%
5y CAGR-$9.784m
-334.0%
1y CAGR-177.7%
3y CAGR-934.3%
5y CAGR-$2.20
-335.7%
1y CAGR-173.5%
3y CAGR-680.1%
5y CAGR$10.046m
$77.938m
Assets$67.892m
Liabilities$44.122m
Debt56.6%
-1x
Debt to EBITDA$1.475m
+477.2%
1y CAGR+1045.6%
3y CAGR+677.3%
5y CAGR